Current perspectives on repeat hepatic resection for colorectal carcinoma: A review

被引:66
作者
Wanebo, HJ [1 ]
Chu, QD [1 ]
Avradopoulos, KA [1 ]
Vezeridis, MP [1 ]
机构
[1] ROGER WILLIAMS MED CTR,DEPT SURG,PROVIDENCE,RI 02908
关键词
D O I
10.1016/S0039-6060(96)80133-4
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background, Recurrence occurs in 65% to 85% of patients after initial hepatectomy for metastases from colorectal cancer. Approximately one half of these have liver metastases, and in 20% to 30% only the liver is involved. Opportunity for resection is frequent limited because of diffuse liver disease or extrahepatic extension, and only about 10% to 25% of these patients have conditions amenable to resection. This current review is focused on the rationale, indications and results of reresection of hepatic metastases pam colorectal cancer. Methods. The major series of liver resection were reviewed, and the cases of repeat resections were culled out. In addition to standard clinical parameters, the indications and timing after initial resection and the survival and subsequent recurrence after repeat resection were recorded. Results. A comprehensive review of the 28 series showed that the mean interval between, the first and second liver resections varied from 9 to 33 months and was about 17.5 months in the two largest series. The median survival in series reporting 10 or more patients was 19 months (mean, 24 months), which is comparable to data in single resection series. In the large French Association series containing 1626 patients with single resections and 144 patients with two resections, the 5-year survival was 25% and 16%, respectively. The recurrence rate after repeat resection is high (greater than 60%), and one half are in the liver. The prognostic factors favoring repeat resection are variable, but they include absence of extrahepatic extension of tumor and a complete resection of the liver metastases. Conclusions, Repeat hepatic liver resection, for metastatic colorectal cancer in. carefully selected patients appears warranted in view of reasonable survival expectations, which approach that of single liver resection. Risk of recurrence is high, however, suggesting the need for rigorous preoperative and intraoperative assessment and postoperative adjuvant therapy.
引用
收藏
页码:361 / 371
页数:11
相关论文
共 74 条
  • [41] MCCORMACK PM, 1993, COLORECTAL CANC, P437
  • [42] CRITERIA FOR SAFE HEPATIC RESECTION
    MIYAGAWA, S
    MAKUUCHI, M
    KAWASAKI, S
    KAKAZU, T
    [J]. AMERICAN JOURNAL OF SURGERY, 1995, 169 (06) : 589 - 594
  • [43] LEVAMISOLE AND FLUOROURACIL FOR ADJUVANT THERAPY OF RESECTED COLON-CARCINOMA
    MOERTEL, CG
    FLEMING, TR
    MACDONALD, JS
    HALLER, DG
    LAURIE, JA
    GOODMAN, PJ
    UNGERLEIDER, JS
    EMERSON, WA
    TORMEY, DC
    GLICK, JH
    VEEDER, MH
    MAILLIARD, JA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (06) : 352 - 358
  • [44] AGGRESSIVE REPEAT LIVER RESECTION FOR HEPATIC METASTASES OF COLORECTAL-CARCINOMA
    NAKAMURA, S
    SAKAGUCHI, S
    NISHIYAMA, R
    SUZUKI, S
    YOKOI, Y
    BABA, S
    MARO, H
    [J]. SURGERY TODAY, 1992, 22 (03) : 260 - 264
  • [45] GENERATION OF PHENOTYPIC DIVERSITY AND PROGRESSION IN METASTATIC TUMOR-CELLS
    NICOLSON, GL
    [J]. CANCER AND METASTASIS REVIEWS, 1984, 3 (01) : 25 - 42
  • [46] HEPATIC RESECTION FOR COLORECTAL LIVER METASTASES - INFLUENCE ON SURVIVAL OF PREOPERATIVE FACTORS AND SURGERY FOR RECURRENCES IN 80 PATIENTS
    NORDLINGER, B
    PARC, R
    DELVA, E
    QUILICHINI, MA
    HANNOUN, L
    HUGUET, C
    [J]. ANNALS OF SURGERY, 1987, 205 (03) : 256 - 263
  • [47] NORDLINGER B, 1992, TREATMENT HEPATIC ME, P129, DOI DOI 10.1007/978-3-642-51873-7_12
  • [48] NORDLINGER B, 1994, HEPATOBILIARY CANC, P57
  • [49] OCONNELL M, 1993, P AN M AM SOC CLIN, V12, P190
  • [50] ODWYER PJ, 1991, EUR J SURG ONCOL, V17, P403